Department of Dermatology, Peking University First Hospital, Beijing, China.
Research Center for Medical Mycology, Peking University, Beijing, China.
J Clin Microbiol. 2019 Aug 26;57(9). doi: 10.1128/JCM.00604-19. Print 2019 Sep.
Invasive aspergillosis caused by triazole-resistant strains of is a growing public health concern, as is the occurrence of mixed infections with triazole-resistant and -susceptible strains. Therefore, it is crucial to develop robust methods to identify triazole-resistant strains of , even in mixtures of triazole-resistant and -susceptible strains of In this work, we developed a robust, highly selective, and broad-range allele-specific TaqMan real-time PCR platform consisting of 7 simultaneous assays that detect TR (a 34-bp tandem repeat in the promoter region), TR, G54W (a change of G to W at position 54), G54R, L98H, Y121F, and M220I mutations in the gene of The method is based on the widely used TaqMan real-time PCR technology and combines allele-specific PCR with a blocking reagent (minor groove binder [MGB] oligonucleotide blocker) to suppress amplification of the wild-type alleles. We used this method to detect triazole-resistant clinical strains of with a variety of gene mutations, as well as the triazole-resistant strains in mixtures of triazole-resistant and -susceptible strains of The method had high efficiency and sensitivity (300 fg/well, corresponding to about 100 CFU per reaction mixture volume). It could promptly detect triazole resistance in a panel of 30 clinical strains of within about 6 h. It could also detect -associated resistance alleles, even in mixtures containing only 1% triazole-resistant strains. These results suggest that this method is robustly able to detect -associated resistance alleles even in mixtures of triazole-resistant and -susceptible strains of and that it should have important clinical applications.
由唑类药物耐药菌株引起的侵袭性曲霉菌病是一个日益严重的公共卫生问题,唑类药物耐药和敏感菌株的混合感染也时有发生。因此,开发可靠的方法来鉴定唑类药物耐药的烟曲霉菌株至关重要,即使是在唑类药物耐药和敏感的烟曲霉菌株混合物中。在这项工作中,我们开发了一种强大、高度选择性和广谱的等位基因特异性 TaqMan 实时 PCR 平台,该平台由 7 个同时进行的检测组成,可检测 TR(启动子区域的 34 个碱基对串联重复)、TR、G54W(位置 54 处 G 突变为 W)、G54R、L98H、Y121F 和 M220I 突变。该方法基于广泛使用的 TaqMan 实时 PCR 技术,将等位基因特异性 PCR 与阻断试剂(小沟结合物[MGB]寡核苷酸阻断剂)相结合,抑制野生型 等位基因的扩增。我们使用该方法检测了具有多种 基因突变的唑类药物耐药临床烟曲霉菌株,以及唑类药物耐药和敏感的烟曲霉菌株混合物中的唑类药物耐药菌株。该方法具有高效率和灵敏度(300 fg/孔,相当于每个反应混合物体积约 100 CFU)。它可以在大约 6 小时内快速检测出 30 株临床烟曲霉菌株中的唑类药物耐药性。它还可以检测到与 - 相关的耐药等位基因,即使混合物中仅含有 1%的唑类药物耐药烟曲霉菌株。这些结果表明,该方法能够可靠地检测到与 - 相关的耐药等位基因,即使是在唑类药物耐药和敏感的烟曲霉菌株混合物中,并且它应该具有重要的临床应用价值。